Drug Profile
Research programme: GABA A receptor subtype agonists - Merck Sharp & Dohme
Alternative Names: L-696; TP-003Latest Information Update: 23 Mar 2010
Price :
$50
*
At a glance
- Originator Merck & Co
- Class Small molecules
- Mechanism of Action GABA A receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Anxiety disorders; Epilepsy
Most Recent Events
- 31 Dec 2009 Discontinued - Preclinical for Anxiety disorders in USA (PO)
- 31 Dec 2009 Discontinued - Preclinical for Epilepsy in USA (unspecified route)
- 13 Jun 2006 Preclinical trials in Epilepsy in USA (unspecified route)